Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-kappa B signaling pathway in HMC-1 human mast cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Beom-Rak | - |
dc.contributor.author | Seo, Hye-Sook | - |
dc.contributor.author | Ku, Jin-Mo | - |
dc.contributor.author | Kim, Gyung-Jun | - |
dc.contributor.author | Jeon, Chan Yong | - |
dc.contributor.author | Park, Jong Hyeong | - |
dc.contributor.author | Jang, Bo-Hyoung | - |
dc.contributor.author | Park, Sun-Ju | - |
dc.contributor.author | Shin, Yong-Cheol | - |
dc.contributor.author | Ko, Seong-Gyu | - |
dc.date.available | 2020-02-28T22:43:38Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2013-11 | - |
dc.identifier.issn | 1023-3830 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14155 | - |
dc.description.abstract | Silibinin is the major active molecule of silymarin, the mixture of flavonolignans extracted from Cirsium japonicum. It has been used for the treatment of hepatitis and inflammation-related diseases. In the present study, the effects of silibinin on allergic inflammation and its signaling were investigated in the induced human mast cells. Cell growth inhibition induced by silibinin was measured by MTS assay. Histamine release was measured by enzyme immunoassay. The tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-8 (IL-8) secreted protein levels and mRNA levels were measured by the ELISA assay and RT-PCR, respectively. The NF-kappa B promoter activity was examined by a luciferase assay. Silibinin suppressed the growth of HMC-1 cells and also reduced the production and mRNA expression of pro-inflammatory cytokines such as TNF-alpha, IL-6, and IL-8. Moreover, silibinin inhibited the nuclear translocation of nuclear factor (NF)-kappa B through inhibition of the phosphorylation of I kappa B alpha and suppressed NF-kappa B transcriptional activity in stimulated HMC-1 cells. Taken together, these results indicate that silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-kappa B signaling pathway in HMC-1 human mast cells, suggesting that silibinin could be used for the treatment of mast cell-derived allergic inflammatory diseases. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER BASEL AG | - |
dc.relation.isPartOf | INFLAMMATION RESEARCH | - |
dc.subject | NECROSIS-FACTOR-ALPHA | - |
dc.subject | CIRSIUM-JAPONICUM DC | - |
dc.subject | GROWTH-INHIBITION | - |
dc.subject | ACTIVATING FACTOR | - |
dc.subject | LIVER | - |
dc.subject | LINE | - |
dc.subject | EXPRESSION | - |
dc.subject | BASOPHILS | - |
dc.subject | MEDICINE | - |
dc.subject | IMMUNITY | - |
dc.title | Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-kappa B signaling pathway in HMC-1 human mast cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000326296300002 | - |
dc.identifier.doi | 10.1007/s00011-013-0640-1 | - |
dc.identifier.bibliographicCitation | INFLAMMATION RESEARCH, v.62, no.11, pp.941 - 950 | - |
dc.identifier.scopusid | 2-s2.0-84888201594 | - |
dc.citation.endPage | 950 | - |
dc.citation.startPage | 941 | - |
dc.citation.title | INFLAMMATION RESEARCH | - |
dc.citation.volume | 62 | - |
dc.citation.number | 11 | - |
dc.contributor.affiliatedAuthor | Kim, Beom-Rak | - |
dc.contributor.affiliatedAuthor | Kim, Gyung-Jun | - |
dc.contributor.affiliatedAuthor | Jeon, Chan Yong | - |
dc.contributor.affiliatedAuthor | Park, Jong Hyeong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Silibinin | - |
dc.subject.keywordAuthor | Cirsium japonicum | - |
dc.subject.keywordAuthor | Allergic inflammation | - |
dc.subject.keywordAuthor | Human mast cells | - |
dc.subject.keywordAuthor | NF-kappa B | - |
dc.subject.keywordAuthor | Pro-inflammatory cytokine | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | CIRSIUM-JAPONICUM DC | - |
dc.subject.keywordPlus | GROWTH-INHIBITION | - |
dc.subject.keywordPlus | ACTIVATING FACTOR | - |
dc.subject.keywordPlus | LIVER | - |
dc.subject.keywordPlus | LINE | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | BASOPHILS | - |
dc.subject.keywordPlus | MEDICINE | - |
dc.subject.keywordPlus | IMMUNITY | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.